Protection from Group B Streptococcal Infection in Neonatal Mice by Maternal Immunization with Recombinant Sip Protein
Open Access
- 1 September 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (9) , 4897-4901
- https://doi.org/10.1128/iai.70.9.4897-4901.2002
Abstract
The protective potential of antibodies directed against group B streptococcus (GBS) Sip surface protein was determined by using the mouse neonatal infection model. Rabbit Sip-specific antibodies administered passively to pregnant mice protected their pups against a GBS lethal challenge. In addition, active immunization with purified recombinant Sip protein of female CD-1 mice induced the production of specific antibodies that also confer protection to the newborn pups against GBS strains of serotypes Ia/c, Ib, II, III, and V. These data confirm that Sip-specific antibodies can cross the placenta and conferred protective immunity against GBS infections.Keywords
This publication has 42 references indexed in Scilit:
- Age-dependent presence of antibodies in rat dams, capable of conferring protection against group BStreptococcusinfection in neonatesFEMS Microbiology Letters, 2001
- Localization of Surface Immunogenic Protein on Group B StreptococcusInfection and Immunity, 2001
- Use of Capsular Polysaccharide–Tetanus Toxoid Conjugate Vaccine for Type II Group BStreptococcusin Healthy WomenThe Journal of Infectious Diseases, 2000
- Safety and Immunogenicity of Capsular Polysaccharide–Tetanus Toxoid Conjugate Vaccines for Group B Streptococcal Types Ia and IbThe Journal of Infectious Diseases, 1999
- Theraputic Potential of Human Antisera to Group B Streptococcal Glycoconjugate Vaccines in Neonatal MiceThe Journal of Infectious Diseases, 1997
- Neonatal Mouse Model of Group B Streptococcal InfectionThe Journal of Infectious Diseases, 1992
- Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.Journal of Clinical Investigation, 1990
- Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B StreptococcusNew England Journal of Medicine, 1988
- Immunodeterminant specificity of human immunity to type III group B streptococcus.The Journal of Experimental Medicine, 1979
- Immunogenicity of polysaccharides from type III, group B Streptococcus.Journal of Clinical Investigation, 1978